原发性甲状腺功能亢进症的手术治疗  

Surgical treatment for Graves' disease

作　　者：丁谷华[1] 汤一麟 

机构地区：[1]上海市普陀区中心医院,200062

出　　处：《上海医学》2001年第7期407-409,共3页Shanghai Medical Journal

摘　　要：目的　为了减少原发性甲亢病手术治疗并发症 ,总结手术治疗原发性甲亢病的临床经验。方法　我院 1980～ 1998年间手术治疗原发性甲亢病患者 10 8例 ,随访 1～ 19年 ,对其中 92例资料完整者进行甲状腺功能试验、自身抗体检测、术后并发症、细胞病理及残留腺体量等方面的评价。结果　无 1例发生近期并发症 ,有 11例发生甲减 ,7例甲亢复发 ,74例正常甲状腺功能。术后甲减是原发性甲亢病术后主要并发症。结论　有手术指征的甲亢患者应该术前进行甲状腺球蛋白抗体、甲状腺微粒体抗体和甲状腺针吸细胞学检查。Objective To sunmelize clinical experience of surgical treatment for Graves' disease as in order to decrease its complication. Methods From Jan. 1980 to Dec.1998, 108 Cases of Graves' disease received surgical therapy in our hospital were followed 1～19 years. 92 Cases with complete clinical material were evaluated, These including thyroid function tests、operative method, Auto antibodies assay of TGA and TMA, complication of postoperation, cytopathology and amount of residual thyroid. Results No necent complication was observed, these were but there were 11 cases with hypothyroidism, 7 cases with hyperthyroidism, 74 cases with euthyroidism. Hypothyroidism of postoperation in Graves disease was the main complication. Conclusion We suggest that hyperthyroidism patients with conventiona lindication of operation should measure TGA、TMA and examine fine needle aspiration biopsy of thyroid.

关 键 词：原发性甲状腺功能亢进 甲状腺球蛋白抗体 甲状腺微粒体抗体 外科手术 

分 类 号：R653[医药卫生—外科学]